These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37024760)

  • 41. Anticoagulation in pulmonary arterial hypertension - association with mortality, healthcare utilization, and quality of life: The Pulmonary Hypertension Association Registry (PHAR).
    Garry JD; Kolaitis NA; Kronmal R; Thenappan T; Hemnes A; Grinnan D; Bull T; Chakinala MM; Horn E; Simon MA; De Marco T;
    J Heart Lung Transplant; 2022 Dec; 41(12):1808-1818. PubMed ID: 36150996
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification of Frailty Using a Claims-Based Frailty Index in the CoreValve Studies: Findings from the EXTEND-FRAILTY Study.
    Strom JB; Xu J; Orkaby AR; Shen C; Charest BR; Kim DH; Cohen DJ; Kramer DB; Spertus JA; Gerszten RE; Yeh RW
    J Am Heart Assoc; 2021 Oct; 10(19):e022150. PubMed ID: 34585597
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment patterns and resource utilization and costs among patients with pulmonary arterial hypertension in the United States.
    Angalakuditi M; Edgell E; Beardsworth A; Buysman E; Bancroft T
    J Med Econ; 2010; 13(3):393-402. PubMed ID: 20608882
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The direct and indirect health care costs associated with pulmonary arterial hypertension among commercially insured patients in the United States.
    Ogbomo A; Tsang Y; Mallampati R; Panjabi S
    J Manag Care Spec Pharm; 2022 Jun; 28(6):608-616. PubMed ID: 35621726
    [No Abstract]   [Full Text] [Related]  

  • 45. Impact of a Claims-Based Frailty Indicator on the Prediction of Long-Term Mortality After Transcatheter Aortic Valve Replacement in Medicare Beneficiaries.
    Kundi H; Valsdottir LR; Popma JJ; Cohen DJ; Strom JB; Pinto DS; Shen C; Yeh RW
    Circ Cardiovasc Qual Outcomes; 2018 Oct; 11(10):e005048. PubMed ID: 30354574
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Incremental burden of disease in patients diagnosed with pulmonary arterial hypertension receiving monotherapy and combination vasodilator therapy.
    Small M; Piercy J; Pike J; Cerulli A
    Adv Ther; 2014 Feb; 31(2):168-79. PubMed ID: 24449285
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Higher Incidence Rates of Comorbidities in Patients with Psoriatic Arthritis Compared with the General Population Using U.S. Administrative Claims Data.
    Kaine J; Song X; Kim G; Hur P; Palmer JB
    J Manag Care Spec Pharm; 2019 Jan; 25(1):122-132. PubMed ID: 29694270
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Right Heart Score for Predicting Outcome in Idiopathic, Familial, or Drug- and Toxin-Associated Pulmonary Arterial Hypertension.
    Haddad F; Spruijt OA; Denault AY; Mercier O; Brunner N; Furman D; Fadel E; Bogaard HJ; Schnittger I; Vrtovec B; Wu JC; de Jesus Perez V; Vonk-Noordegraaf A; Zamanian RT
    JACC Cardiovasc Imaging; 2015 Jun; 8(6):627-38. PubMed ID: 25981508
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Validation of claims-based algorithms for pulmonary arterial hypertension.
    Papani R; Sharma G; Agarwal A; Callahan SJ; Chan WJ; Kuo YF; Shim YM; Mihalek AD; Duarte AG
    Pulm Circ; 2018; 8(2):2045894018759246. PubMed ID: 29480064
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development and Validation of Algorithms to Identify Pulmonary Arterial Hypertension in Administrative Data.
    Gillmeyer KR; Nunez ER; Rinne ST; Qian SX; Klings ES; Wiener RS
    Chest; 2021 May; 159(5):1986-1994. PubMed ID: 33345949
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cardiac magnetic resonance imaging as a prognostic biomarker in treatment-naïve pulmonary hypertension.
    Jose A; Kher A; O'Donnell RE; Elwing JM
    Eur J Radiol; 2020 Feb; 123():108784. PubMed ID: 31862635
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Medication use by US patients with pulmonary hypertension associated with chronic obstructive pulmonary disease: a retrospective study of administrative data.
    Weiss TJ; Rosen Ramey D; Yang L; Liu X; Patel MJ; Rajpathak S; Bajwa EK; Lautsch D
    BMC Pulm Med; 2022 Oct; 22(1):383. PubMed ID: 36258171
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association of Borderline Pulmonary Hypertension With Mortality and Hospitalization in a Large Patient Cohort: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program.
    Maron BA; Hess E; Maddox TM; Opotowsky AR; Tedford RJ; Lahm T; Joynt KE; Kass DJ; Stephens T; Stanislawski MA; Swenson ER; Goldstein RH; Leopold JA; Zamanian RT; Elwing JM; Plomondon ME; Grunwald GK; Barón AE; Rumsfeld JS; Choudhary G
    Circulation; 2016 Mar; 133(13):1240-8. PubMed ID: 26873944
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Impact of Frailty on Long-Term Patient-Oriented Outcomes after Emergency General Surgery: A Retrospective Cohort Study.
    Lee KC; Streid J; Sturgeon D; Lipsitz S; Weissman JS; Rosenthal RA; Kim DH; Mitchell SL; Cooper Z
    J Am Geriatr Soc; 2020 May; 68(5):1037-1043. PubMed ID: 32043562
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Change in a Claims-Based Frailty Index, Mortality, and Health Care Costs in Medicare Beneficiaries.
    Shi SM; Steinberg N; Oh G; Olivieri-Mui B; Sison S; McCarthy EP; Kim DH
    J Gerontol A Biol Sci Med Sci; 2023 Jul; 78(7):1198-1203. PubMed ID: 36630699
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Pulmonary arterial hypertension as leading manifestation of methylmalonic aciduria: clinical characteristics and gene testing in 15 cases].
    Liu XQ; Yan H; Qiu JX; Zhang CY; Qi JG; Zhang X; Xiao HJ; Yang YL; Chen YH; Du JB
    Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Oct; 49(5):768-777. PubMed ID: 29045954
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparing Survey-Based Frailty Assessment to Medicare Claims in Predicting Health Outcomes and Utilization in Medicare Beneficiaries.
    Wu S; Mulcahy J; Kasper JD; Kan HJ; Weiner JP
    J Aging Health; 2020; 32(7-8):764-777. PubMed ID: 31148491
    [No Abstract]   [Full Text] [Related]  

  • 58. A Real-World Analysis of Patient Characteristics and Predictors of Hospitalization Among US Medicare Beneficiaries with Respiratory Syncytial Virus Infection.
    Wyffels V; Kariburyo F; Gavart S; Fleischhackl R; Yuce H
    Adv Ther; 2020 Mar; 37(3):1203-1217. PubMed ID: 32026380
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Patient Frailty and Functional Use of Hemodialysis Vascular Access: A Retrospective Study of the US Renal Data System.
    Woo K; Gascue L; Norris K; Lin E
    Am J Kidney Dis; 2022 Jul; 80(1):30-45. PubMed ID: 34906627
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Systemic BP and heart rate as prognostic indicators in pulmonary arterial hypertension.
    Bersohn MM; Turner MP; Traiger GL; Frost AE; Shapiro S
    Chest; 2013 Sep; 144(3):959-965. PubMed ID: 23598723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.